1615 related articles for article (PubMed ID: 15860265)
21. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
Aka JA; Mazumdar M; Lin SX
Mol Cell Endocrinol; 2009 Mar; 301(1-2):183-90. PubMed ID: 19038308
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
Selcer KW; Hegde PV; Li PK
Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
[TBL] [Abstract][Full Text] [Related]
23. Enzymes as modulators in malignant transformation.
Vihko P; Herrala A; Härkönen P; Isomaa V; Kaija H; Kurkela R; Li Y; Patrikainen L; Pulkka A; Soronen P; Törn S
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):277-83. PubMed ID: 15860271
[TBL] [Abstract][Full Text] [Related]
24. Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues.
Chetrite GS; Thomas JL; Shields-Botella J; Cortes-Prieto J; Philippe JC; Pasqualini JR
Anticancer Res; 2005; 25(4):2827-30. PubMed ID: 16080533
[TBL] [Abstract][Full Text] [Related]
25. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S
Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614
[TBL] [Abstract][Full Text] [Related]
26. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
[TBL] [Abstract][Full Text] [Related]
27. New developments in intracrinology of human breast cancer: estrogen sulfatase and sulfotransferase.
Sasano H; Nagasaki S; Miki Y; Suzuki T
Ann N Y Acad Sci; 2009 Feb; 1155():76-9. PubMed ID: 19250194
[TBL] [Abstract][Full Text] [Related]
28. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
29. Estrogen inhibits cell proliferation through in situ production in human thymoma.
Ishibashi H; Suzuki T; Suzuki S; Moriya T; Kaneko C; Nakata T; Sunamori M; Handa M; Kondo T; Sasano H
Clin Cancer Res; 2005 Sep; 11(18):6495-504. PubMed ID: 16166425
[TBL] [Abstract][Full Text] [Related]
30. Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors.
Laplante Y; Rancourt C; Poirier D
Mol Cell Endocrinol; 2009 Mar; 301(1-2):146-53. PubMed ID: 18812208
[TBL] [Abstract][Full Text] [Related]
31. Effects of Org OD14 (Livial) and its metabolites on 17 beta-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells.
Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
Anticancer Res; 1999; 19(1A):261-7. PubMed ID: 10226552
[TBL] [Abstract][Full Text] [Related]
32. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
[TBL] [Abstract][Full Text] [Related]
33. Progestins and breast cancer.
Pasqualini JR; Paris J; Sitruk-Ware R; Chetrite G; Botella J
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):225-35. PubMed ID: 9699877
[TBL] [Abstract][Full Text] [Related]
34. Estrogen sulfotransferases in breast and endometrial cancers.
Pasqualini JR
Ann N Y Acad Sci; 2009 Feb; 1155():88-98. PubMed ID: 19250196
[TBL] [Abstract][Full Text] [Related]
35. Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence.
Pasqualini JR; Chetrite G; Nguyen BL; Maloche C; Delalonde L; Talbi M; Feinstein MC; Blacker C; Botella J; Paris J
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):407-12. PubMed ID: 7626488
[TBL] [Abstract][Full Text] [Related]
36. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer.
Pasqualini JR; Schatz B; Varin C; Nguyen BL
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):323-9. PubMed ID: 1580921
[TBL] [Abstract][Full Text] [Related]
37. Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines.
Read LD; Keith D; Slamon DJ; Katzenellenbogen BS
Cancer Res; 1990 Jul; 50(13):3947-51. PubMed ID: 1972345
[TBL] [Abstract][Full Text] [Related]
38. Paradoxical effect of estradiol: it can block its own bioformation in human breast cancer cells.
Pasqualini JR; Chetrite G
J Steroid Biochem Mol Biol; 2001 Jul; 78(1):21-4. PubMed ID: 11530280
[TBL] [Abstract][Full Text] [Related]
39. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
40. Biological effects of progestins in breast cancer.
Pasqualini JR; Ebert C; Chetrite GS
Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():44-52. PubMed ID: 12227886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
